The DOI matches its Crossref record.
Interactions between Medications Employed in Treating Benign Prostatic Hyperplasia and Food—A Short Review
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Previous studies state that food tends to decrease finasteride Cmax and delay tmax, though these changes do not affect the total bioavailability of the drug, and thus, it may be taken with or without a meal [22,46].”
From Food Administration and Not Genetic Variants Causes Pharmacokinetic Variability of Tadalafil and Finasteride (2023) · cites this paper as [46]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 24
- Praveen, 2013, Benign prostatic hyperplasia: updated review, Int. Res. J. Pharm., 4, 45, 10.7897/2230-8407.04808 · DOI
- Hollingsworth, 2014, Lower urinary tract symptoms in men, BMJ, 349, g4474, 10.1136/bmj.g4474 · DOI
- Kapoor, 2012, Benign prostatic hyperplasia (BPH) management in the primary care setting, Can. J. Urol., 19, 10
- Edwards, 2008, Diagnosis and management of benign prostatic hyperplasia, Am. Fam. Physician, 77, 1403
- Rittmaster, 2008, 5α-reductase inhibitors in benign prostatic hyperplasia and prostate cancer risk reduction, Best Pract. Res. Clin. Endocrinol. Metab., 22, 389, 10.1016/j.beem.2008.01.016 · DOI
- Bailey, 2013, Grapefruit-medication interactions: forbidden fruit or avoidable consequences?, CMAJ, 185, 309, 10.1503/cmaj.120951 · DOI
- Mazi-Kotwal, 2012, Drug Interactions with grapefruit juice, BJMP, 5, a538
- Vuichoud, 2015, Benign prostatic hyperplasia: epidemiology, economics and evaluation, Can. J. Urol., 22, 1
- Heuberger, 2012, Polypharmacy and food–drug interactions among older persons: a review, J. Nutr. Gerontol. Geriatr., 31, 325, 10.1080/21551197.2012.729902 · DOI
- Wilde, 1993, Alfuzosin, Drugs, 45, 410, 10.2165/00003495-199345030-00008 · DOI
- Deepalakshmi, 2014, Grapefruit and medications may be a deadly mix- an overview, J. Pharm. BioSci., 3, 80
- Kawano, 2000, Interaction of alcohol and an α1-blocker on ambulatory blood pressure in patients with essential hypertension, Am. J. Hypertens., 13, 307, 10.1016/S0895-7061(99)00188-0 · DOI
- Chung, 1999, Clinical pharmacokinetics of doxazosin in a controlled-release gastrointestinal therapeutic system (GITS) formulation, Br. J. Clin. Pharmacol., 48, 678, 10.1046/j.1365-2125.1999.00067.x · DOI
- Conway, 1993, The effects of food on the oral bioavailability of doxazosin in hypertensive subjects, Drug Invest., 6, 90, 10.1007/BF03258458 · DOI
- Montorsi, 2010, Profile of silodosin, Eur. Urol., 9, 491, 10.1016/j.eursup.2010.04.001 · DOI
- Yoshida, 2007, Silodosin, a novel selective α1A-adrenoceptor selective antagonist for the treatment of benign prostatic hyperplasia, Exp. Opin. Investig. Drugs, 16, 1955, 10.1517/13543784.16.12.1955 · DOI
- Michel, 2005, Cardiovascular safety of tamsulosin modified release in the fasted and fed state in elderly healthy subjects, Eur. Urol. Suppl., 4, 9, 10.1016/j.eursup.2004.11.003 · DOI
- Michel, 2005, The pharmacokinetic profile of tamsulosin oral controlled absorption system (OCAS®), Eur. Urol. Suppl., 4, 15, 10.1016/j.eursup.2004.11.002 · DOI
- Chapple, 2006, Pharmacokinetic profile of tamsulosin OCAS, BJU Int., 98, 9, 10.1111/j.1464-410X.2006.06494.x · DOI
- Takanaga, 2000, Relationship between time after intake of grapefruit juice and the effect on the pharmacokinetics and pharmacodynamics of nisoldipine in healthy subjects, Clin. Pharmacol. Ther., 67, 201, 10.1067/mcp.2000.104215 · DOI
- McNeil, 1991, The influence of food on the oral bioavailability of terazosin, Br. J. Clin. Pharmacol., 32, 775, 10.1111/j.1365-2125.1991.tb03991.x · DOI
- Steiner, 1996, Clinical pharmacokinetics and pharmacodynamics of finasteride, Clin. Pharmacokinet., 30, 16, 10.2165/00003088-199630010-00002 · DOI · Paper page
- McClellan, 1999, Finasteride, Drugs, 57, 111, 10.2165/00003495-199957010-00014 · DOI
- Maltz, 2009, Medication and food issues for overactive bladder/lower urinary tract symptoms: when do we eat?, Curr. Bladder Dysfunct. Rep., 4, 93, 10.1007/s11884-009-0014-2 · DOI
Cited by
Levothyroxine interactions with food and dietary supplements – a systematic review
Wiesner, A., Gajewska, D., & Paśko, P. (2021) · Pharmaceuticals · doi:10.3390/ph14030206 · Cited by 85
“Heuberger [106] and Pa ś ko et al. [107] provided a few reasons for that, such as undefined framework study, hardly available appropriate samples, or measurement difficulties.”
BackgroundVillapalos-García, G., Zubiaur, P., Marián-Revilla, C., Soria-Chacartegui, P., Navares-Gómez, M., Mejía-Abril, G., Rodríguez-Lopez, A., González-Iglesias, E., Martín-Vílchez, S., Román, M., et al. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13111566 · Cited by 4
Metadata
- Authors
- Paśko, P., Rodacki, T., Domagała-Rodacka, R., & Owczarek, D.
- Venue
- Biomedicine & Pharmacotherapy
- Publisher
- Elsevier BV
- Published
- 2016-10
- Volume
- 83
- Pages
- 1141-1145
- ISSN
- 0753-3322
- Cited by
- 13
- References
- 0
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
